Infection risks associated with daratumumab-containing regimens in multiple myeloma: a systematic review and meta-analysis

Authors

Institutions

Publication Details

Journal
Frontiers in Oncology
Published
2026-01-06
DOI
https://doi.org/10.3389/fonc.2025.1729177
Primary Topic
Multiple Myeloma Research and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Infection risks associated with daratumumab-containing regimens in multiple myeloma: a systematic review and meta-analysis

Zeng-Yi Huang, Xiaolian Liu, Chao-Han Luo, Ting Li
Frontiers in Oncology
Multiple Myeloma Research and Treatments
article

Infection risks associated with daratumumab-containing regimens in multiple myeloma: a systematic review and meta-analysis

Zeng-Yi Huang, Xiaolian Liu, Chao-Han Luo, Ting Li
article en

Abstract

No abstract available for this paper.
Frontiers in OncologyVol. 15
Macau University of Science and Technology (MO), University of Macau (MO), Gaozhou People's Hospital (CN)
Good health and well-being
Openalex Percentile: Top 96%
Multiple Myeloma Research and Treatments
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Infection risks associated with daratumumab-containing regimens in multiple myeloma: a systematic review and meta-analysis — Zeng-Yi Huang, Xiaolian Liu, et al. · Frontiers in Oncology (2026) | TGRS Research Map | TGRS